PRLD vs UBER · rev $6.5M vs P/E 18, rev $52.02B
Prelude Therapeutics Inc (PRLD) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
PRLD currently screens at market cap $346.5M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the PRLD and UBER stock pages for the full models.
Not investment advice.